Evidence map›Paper›PMID 39274184›Full record

ArticleJournal of clinical medicine2024

Circulating Interleukin-22 in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Augusto Ferreira Correia, Carolina Gomes Cavalcanti de Oliveira, Dinaldo Cavalcanti de Oliveira, Michelly Cristina Pereira, Flavio Alisson Carvalho, Estevão Campos Carvalho Martins, Dinaldo Cavalcanti de Oliveira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Augusto Ferreira CorreiaInternal Medicine Department, Cardiology Division, Federal University of Pernambuco, Recife 50670-901, Brazil.
Carolina Gomes Cavalcanti de OliveiraInternal Medicine Department, Maurício de Nassau University, Recife 51021-140, Brazil.
Dinaldo Cavalcanti de OliveiraInternal Medicine Department, Faculty of Medicine of Sertão, Arcoverde 56512-670, Brazil.
Michelly Cristina PereiraInternal Medicine Department, Cardiology Division, Federal University of Pernambuco, Recife 50670-901, Brazil.
Flavio Alisson CarvalhoMestre Vitalino Hospital, Caruaru 55015-901, Brazil.
Estevão Campos Carvalho MartinsGaleão Air Force Hospital, Rio de Janeiro 21941-353, Brazil.
Dinaldo Cavalcanti de OliveiraInternal Medicine Department, Cardiology Division, Federal University of Pernambuco, Recife 50670-901, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute coronary syndrome (ACS) represents an important clinical manifestation of coronary artery disease (CAD) and is characterized by a particularly poor prognosis. Myocardial reperfusion through primary percutaneous coronary intervention (PPCI) is imperative in the event of acute ST elevation myocardial infarction (STEMI). Interleukin-22 (IL-22) regulates immune and inflammatory responses. This interleukin has been described in the scenario of the CAD, but there are no data in patients with STEMI undergoing PPCI.

Indexed as

ACSatherosclerosisIL-22STEMI

Identifiers

PMID39274184
PMCPMC11396034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.